期刊文献+

凝血因子基因突变及MTHFR/C677T基因多态性与深静脉血栓形成的关系 被引量:9

原文传递
导出
摘要 我们应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对103例深静脉血栓形成(DVT)患者及106名正常对照进行了凝血因子Ⅴ(FⅤ)Leiden、FⅡ/G20210A、FⅫ/V341。以及MTHFR/C677T基因多态性的检测分析,旨在探讨这些遗传多态因子与DVT之间可能的相关性。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第3期197-198,共2页 Chinese Journal of Hematology
基金 河南省高校杰出人才创新工程基金(2005KYCX020) 河南省杰出青年基金(0612001300)
  • 相关文献

参考文献9

  • 1Frosst P,Blom H J,Mulinare J,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylene-tetrahydrofolate reductase.Nat Genet,1995,10:111-117.
  • 2Ridker PM,Hennekens CH,Lindpaintner K,et al.Mutation in the gene coding for coagulation factor Ⅴ and the risk of myocardial infarction,stroke,and venous thrombosis in apparently.N Engl J Med,1995,6:912-916.
  • 3Poort SR,Rosendaal FR,Reitsma PH,et al.A common genetic variation in the 3 '-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis.Blood,1996,88:3698-3702.
  • 4Franco RF,Pazin-Filho A,Tavella MH,et al.Factor ⅩⅢ val34leu and the risk of myocardial infarction.Haematologica,2000,85:67-71.
  • 5Soria JM,Almasy L,Souto JC,et al.Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.Blood,2000,95:2780-2785.
  • 6Zivelin A,Rosenberg N,Fairer S,et al.A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.Blood,1998,92:1119-1124.
  • 7姜剑军,张柏根,张皓.FV_(Leiden)和FⅡ G20210A与中国汉族深静脉血栓形成的相关性[J].上海第二医科大学学报,2003,23(2):111-114. 被引量:4
  • 8Zheng H,Tzeng CC,Butt C,et al.An extremely low prevalence of factor Ⅴ Leiden,F Ⅱ G20210A and FXⅢV34L in Taiwan Chinese population.Thromb Haemost,2002,87:1081-1082.
  • 9王美堂,李强,韩凤来,姚小鹏.血浆叶酸、同型半胱氨酸水平及亚甲基四氢叶酸还原酶基因突变与静脉血栓栓塞症[J].中华内科杂志,2004,43(8):591-594. 被引量:15

二级参考文献22

  • 1黄一宁,赵宇岚,李舜伟.同型半胱氨酸和MTHFR基因多态性与缺血性脑血管病的关系[J].中华医学杂志,2002,82(2):119-122. 被引量:54
  • 2关月,罗佳滨,牟春平,姜亚东,张景泰.深部静脉血栓与凝血因子V基因突变的关系[J].中华心血管病杂志,1996,24(4):296-298. 被引量:3
  • 3Den Heijer M. Homocysteine and venous thrombosis. In: Robinson K, ed. Homocysteine and vascular disease. Netherlands: Kluwer Academic Publishers ,2000. 239-252.
  • 4De Stefano V, Casorelli I, Rossi E, et al. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost ,2000,26:305-311.
  • 5Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol, 1996,106:709-722.
  • 6Eichinger S, Stumpflen A, Hirscbl M, et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost, 1998,80: 566 -569.
  • 7Mainou Cid C, Garcia Giralt N, Vilaseca Busca MA, et al.Hyperhomocystinemia and 677C T methylenetetrahydrofolate reductase polymorphism as a cardiovascular risk factor in childhood.An Esp Pediatr,2002.56:402-408.
  • 8Pita ML, Delgado MJ. Folate administration increases n-3polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb Haemost, 2000,84:420 -423.
  • 9Title LM, Cummings PM, Giddens K, et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol,2000,36:758-765.
  • 10Quere I, Perneger TV, Zittoun J,et al. Red blood cell methyffolate and plasma homocysteine as risk factors for venous thromboembolism:a matched case-control study. Lancet,2002,359:747-752.

共引文献17

同被引文献106

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部